Low Dose G-CSF to Augment Host Defense and Counteract Progression of Sepsis

  • M. Weiss
  • E. M. Schneider
  • P. Radermacher
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1996)


Multiple trauma patients and patients undergoing major surgical operations are predisposed to life-threatening sepsis by an apparently acquired immunological deficiency, which is accompanied by a high mortality rate (40 to 60%) [1]. Neutrophils represent the first line of defense against invading bacteria. However, impaired neutrophil function has been reported in severely injured patients [2] and in patients during early septic shock [3]. Surgery resulted in further depression of neutrophil function in patients with intra-peritoneal infections [4]. In these patients, relapses of infections were associated with a diminution of neutrophil function prior to any clinical evidence for infection [4]. Thus, patients at risk of sepsis or with sepsis might benefit from prophylactic augmentation and restoration of neutrophil function. Unfortunately, until recently, there has been no choice to counteract granulocyte dysfunctions which have been described in posttraumatic patients [2]. However, in mice, recombinant human granulocyte colony-stimulating factor (rhG-CSF) improved survival in a well-established sepsis model [5]. G-CSF is one of the important hemopoietic factors which plays a central role in precursor cell proliferation and differentiation into neutrophils [6]. In addition to the stimulation of proliferation and maturation, G-CSF enhances a variety of functions of neutrophils, including chemotaxis [7], superoxide generation [8], bactericidal function [9] and phagocytic activity [9]. Moreover, G-CSF may have beneficial effects on feedback regulation of cytokines [5, 10]. Thus, G-CSF might activate neutrophils on the one hand and provide an anti-inflammatory effect on the other.


Septic Shock Systemic Inflammatory Response Syndrome Adult Respiratory Distress Syndrome Neutrophil Function Membrane Attack Complex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119: 771–778PubMedGoogle Scholar
  2. 2.
    Lanser ME, Mao P, Brown G, Coleman B, Siegel JH (1985) Serum-mediated depression of neutrophil chemiluminescence following blunt trauma. Ann Surg 202: 111–118PubMedCrossRefGoogle Scholar
  3. 3.
    Vespa siano MC, Lewandoski JR, Zimmerman JJ (1993) Longitudinal analysis of neutrophil superoxide anion generation in patients with septic shock. Crit Care Med 21: 666–672CrossRefGoogle Scholar
  4. 4.
    Solomkin JS, Bauman MP, Nelson RD, Simmons RL (1981) Neutrophils dysfunction during the course of intra-abdominal infection. Ann Surg 194: 9–17PubMedCrossRefGoogle Scholar
  5. 5.
    Gorgen I, Hartung T, Leist M, et al (1992) Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-a. J Immunol 149: 919–924Google Scholar
  6. 6.
    Lieschke GJ, Burgess A W (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327: 28–35PubMedCrossRefGoogle Scholar
  7. 7.
    Wang JM, Chen ZG, Colella S, et al (1988) Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood 72: 1456–1460PubMedGoogle Scholar
  8. 8.
    Nathan CF (1989) Respiratory burst in adherent human neutrophils: Triggering by colony- stimulating factors CSF-GM and CSF-G. Blood 73: 301–306PubMedGoogle Scholar
  9. 9.
    Roilides E, Walsh TJ, Pizzo PA, Rubin M (1991) Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 163: 579–583PubMedCrossRefGoogle Scholar
  10. 10.
    Kanazawa M, Ishizaka A, Hasegawa N, Suzuki Y, Yokohama T (1992) Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Respir Dis 145: 1030–1035PubMedCrossRefGoogle Scholar
  11. 11.
    Sprikkelman A, de Wolf JTHM, Vellenga E (1994) The application of hematopoietic growth factors in drug-induced agranulocytosis: A review of 70 cases. Leukemia 8: 2031–2036PubMedGoogle Scholar
  12. 12.
    Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115: 457–469PubMedGoogle Scholar
  13. 13.
    Bone RC (1994) Gram-positive organisms and sepsis. Arch Intern Med 154: 26–34PubMedCrossRefGoogle Scholar
  14. 14.
    Lynn WA, Golenbock DT (1992) Lipopolysaccharide antagonists. Immunol Today 13: 271–276PubMedCrossRefGoogle Scholar
  15. 15.
    Keene AR, Cullen DJ (1983) Therapeutic intervention scoring system: Update 1983. Crit Care Med 11: 1–3PubMedCrossRefGoogle Scholar
  16. 16.
    Bone RC (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864–874CrossRefGoogle Scholar
  17. 17.
    Weiss M, Gross-Weege W, Harms B, Schneider EM (1996) Filgrastim (rhG-CSF) related modulation of the inflammatory response in patients at risk of sepsis or with sepsis. Cytokine (in press)Google Scholar
  18. 18.
    Schmitz S, Franke H, Brusis J, Wichmann HE (1993) Quantification of the cell kinetic effects of G-CSF using a model of human granulopoiesis. Exp Hematol 21: 755–760PubMedGoogle Scholar
  19. 19.
    Lindemann A, Hermann F, Oster W, et al (1989) Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 74: 2644–2651PubMedGoogle Scholar
  20. 20.
    Weiss M, Gross-Weege W, Schneider M, et al (1995) Enhancement of neutrophil function by in vivo fllgrastim treatment for prophylaxis of sepsis in surgical intensive care patients. J Crit Care 10: 21–26PubMedCrossRefGoogle Scholar
  21. 21.
    Selig C, Nothdurft W (1995) Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections. Infect Immun 63: 104–109PubMedGoogle Scholar
  22. 22.
    Konig B, Konig W (1994) Effect of growth factors on Escherichia coli alpha-hemolysininduced mediator release from human inflammatory cells: Involvement of the signal transduction pathway. Infect Immun 62: 2085–2093PubMedGoogle Scholar
  23. 23.
    Weiss M, Gross-Weege W, Wernet P, Neidhardt H, Harms B, Schneider M (1994) Filgrastim (rhG-CSF) for prophylaxis and therapy of sepsis in surgical intensive care patients: Neutrophil function. Clinical Intensive Care (Suppl) 5: 96 (Abst)Google Scholar
  24. 24.
    Simms HH, D’Amico R (1994) Polymorphonuclear leukocyte dysregulation during the systemic inflammatory response syndrome. Blood 83: 1398–1407PubMedGoogle Scholar
  25. 25.
    Simms HH, D’Amico R (1994) Granulocyte colony-stimulating factor reverses septic shock-induced polymorphonuclear leukocyte dysfunction. Surgery 115: 85–93PubMedGoogle Scholar
  26. 26.
    Repp R, Valerius T, Sendler A, et al (1991) Neutrophils express the high affinity receptor for IgG (FcgRI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 78: 885–889PubMedGoogle Scholar
  27. 27.
    Kerst JM, de Haas M, van der Schoot E, et al (1993) Recombinant granulocyte colonystimulating factor administration to healthy volunteers: Induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 82: 3265–3272PubMedGoogle Scholar
  28. 28.
    Erbe DV, Collins JE, Shen L, Graziano RF, Fanger MW (1990) The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells. Mol Immuno127: 57–67Google Scholar
  29. 29.
    De Haas M, Kerst JM, Van der Schoot CE, et al (1994) Granulocyte colony-stimulating factor administration to healthy volunteers analysis of the immediate activating effects on circulating neutrophils. Blood 84: 3885–3894PubMedGoogle Scholar
  30. 30.
    Kuijpers TW, Tool ATJ, van der Schoot CE, et al (1991) Membrane surface antigen expression on neutrophils: A reappraisal of the use of surface markers for neutrophil activation. Blood 78: 1105–1111PubMedGoogle Scholar
  31. 31.
    Clancy RM, Leszczynska-Piziak J, Abramson SB (1992) Nitric oxide, an endothelial cell relaxation factor, inhibitis neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90: 1116–1121PubMedCrossRefGoogle Scholar
  32. 32.
    Springer TA (1990) Adhesion receptors of the immune system. Nature 346: 425–434PubMedCrossRefGoogle Scholar
  33. 33.
    Hogg N (1992) Roll, roll, roll your leucocyte gently down the vein. Immunol Today 13: 113–115PubMedCrossRefGoogle Scholar
  34. 34.
    Strieter RM, Kunkel SL (1994) Acute lung injury: The role of cytokines in the elicitation of neutrophils. J Invest Med 42: 643–649Google Scholar
  35. 35.
    Rao KM, Currie MS, Cohen HJ, Peters WP (1994) Alterations in L-selectin expression and elastase activity in neutrophils from patients receiving granulocyte colony-stimulating factor alone or in conjunction with high-dose chemotherapy with autologous bone marrow transplantation. Lymphokine Cytokine Res 13: 383–390PubMedGoogle Scholar
  36. 36.
    Ohsaka A, Saionji K, Sato N, Mori T, Ishimoto K, Inamatsu T (1993) Granulocyte colony-stimulating factor downregulates the surface expression of the human leukocyte adhesion molecule-Ion human neutrophils in vitro and in vivo. Br J Haematol 84: 574–580PubMedCrossRefGoogle Scholar
  37. 37.
    Tedder TF, Steeber DA, Pizcueta P (1995) L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med 181: 2259–2264PubMedCrossRefGoogle Scholar
  38. 38.
    Cowley HC, Heney D, Gearing AJH, Hemingway I, Webster NR (1994) Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study. Crit Care Med 22: 651–657PubMedCrossRefGoogle Scholar
  39. 39.
    Sessler CN, Windsor AC, Schwartz M, et al (1995) Circulating ICAM-1 is increased in septic shock. Am J Respir Crit Care Med 151: 1420–1427PubMedGoogle Scholar
  40. 40.
    Xu BH, Gonzalo JA, Pierre YS, et al (1994) Leukocytosis and resistance to septic shock in intercellular adhesion molecule I-deficient mice. J Exp Med 180: 95–109PubMedCrossRefGoogle Scholar
  41. 41.
    Aoki Y, Hiromatsu K, Kobayashi N, et al (1995) Protective effect of granulocyte colonystimulating factor against T-cell-mediated lethal shock triggered by superantigens. Blood 86: 1420–1427PubMedGoogle Scholar
  42. 42.
    Toumanen EI, Austrian R, Masure HR (1995) Pathogenesis of pneumococcal infection. N Engl J Med 11: 1280–1284Google Scholar
  43. 43.
    Kuhns DB, Alvord WG, Gallin JI (1995) Increased circulating cytokines, cytokine antagonists and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 171: 145–152PubMedCrossRefGoogle Scholar
  44. 44.
    Hackett SP, Stevens DL (1992) Streptococcal toxic shock syndrome: Synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis 165: 879–885PubMedCrossRefGoogle Scholar
  45. 45.
    Lorenz W, Reimund KP, Weitzel F, et al (1994) Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery 116: 925–934PubMedGoogle Scholar
  46. 46.
    Eichacker PQ, Waisman Y, Natanson C, et al (1994) Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol 77: 2366–2373PubMedGoogle Scholar
  47. 47.
    Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328: 106–113PubMedCrossRefGoogle Scholar
  48. 48.
    Hartung T, Docke WD, Gantner F, et al (1995) Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85: 2482–2489PubMedGoogle Scholar
  49. 49.
    van Zee KJ, DeForge LE, Fischer E, et al (1991) IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 146: 3478–3482PubMedGoogle Scholar
  50. 50.
    Kilgore KS, Shen JP, Miller BF, Ward PA, Warren JS (1995) Enhancement by the complement membrane attack complex of tumor necrosis factor-α induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 155: 1434–1441PubMedGoogle Scholar
  51. 51.
    Denzlinger C, Holler E, Reisbach G, Hiller E, Wilmanns W (1994) Granulocyte colonystimulating factor inhibits the endogenous leukotriene production in tumour patients. Br J Haematol 86: 881–882PubMedCrossRefGoogle Scholar
  52. 52.
    Emminger W, Emminger-Schmidmeier W, Peters C, et al (1990) Capillary leak syndrome during low dose granulocyte-macrophage colony-stimulating factor (rh GMCSF) treatment of a patient in a continuous febrile state. Blut 61: 219–221PubMedCrossRefGoogle Scholar
  53. 53.
    Izumi T, Muroi K, Takatoku MA, Imagawa S, Hatake K, Miura Y (1994) Development of acute myeloblastic leukaemia in a case of aplastic anaemia treated with granulocyte colony-stimulating factor. Br J Haematol 87: 666–668PubMedCrossRefGoogle Scholar
  54. 54.
    Kojima S, Inaba J, Kondo M, Kato K, Matsuyama T, Kodera Y (1995) Development of myelodysplasia with monosomy 7 in children with severe aplastic anemia after treatment with recombinant granulocyte colony-stimulating factor. Exp Hematol 230: 901–906Google Scholar
  55. 55.
    Schilero GJ, Oropello J, Benjamin E (1995) Impairment in gas exchange after granulocyte colony-stimulating factor (G-CSF) in a patient with the adult respiratory distress syndrome. Chest 107: 276–278PubMedCrossRefGoogle Scholar
  56. 56.
    Demuynck H, Zachee P, Verhoef GEG, et al (1995) Risk of rhG-CSF treatment in druginduced agranulocytosis. Ann Hematol 70: 143–147PubMedCrossRefGoogle Scholar
  57. 57.
    Heyll A, Aul C, Gogolin F, Thomas M, et al (1991) Granulocyte colony-stimulating factor (G-CSF) treatment in a neutropenic leukemia patient with diffuse interstitial pulmonary infiltrates. Ann Hematol 63: 328–332PubMedCrossRefGoogle Scholar
  58. 58.
    Gillis S (1991) Cytokine receptors. Curr Opin Immunol 3: 315–319PubMedCrossRefGoogle Scholar
  59. 59.
    Tweardy DJ, Burkhardt AL, Bolen J, Geahlen RL, Corey SJ (1993) G-CSF receptor signaling involves SRC-related and non-SRC-related tyrosine kinases with evidence of a threecomponent complex. In: Abraham NG, Shadduck RK, Levine AS, Takaku F (eds) Molecular Biology of Haematopoiesis. Vol 3. Intercept, Andover, pp 607–619Google Scholar
  60. 60.
    Tian SS, Lamb P, Seidel HM, Stein RB, Rosen J (1994) Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 84: 1760–1764PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • M. Weiss
  • E. M. Schneider
  • P. Radermacher

There are no affiliations available

Personalised recommendations